ArticleMolecular therapy. Nucleic acids2017

miR-133a Promotes TRAIL Resistance in Glioblastoma via Suppressing Death Receptor 5 and Activating NF-κB Signaling.

Shan-Shan Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.